Krystal Biotech’s KB105 Granted Orphan Drug Designation by the F
KRYS: Krystal Biotech
2018-08-09 08:00:00
Krystal Biotech’s KB105 Granted Orphan Drug Designation by the FDA to Treat Patients With TGM-1 Deficient Autosomal Recessive Congenital Ichthyosis
2018-08-09 08:00:00
Krystal Biotech’s KB105 Granted Orphan Drug Designation by the FDA to Treat Patients With TGM-1 Deficient Autosomal Recessive Congenital Ichthyosis